Evidence map›Paper›PMID 36161914›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Generation of mega brown adipose tissue in adults by controlling brown adipocyte differentiation in vivo.

Qiqiao Du, Jieyu Wu, Carina Fischer, Takahiro Seki, Xu Jing, Juan Gao, Xingkang He, Kayoko Hosaka, Le Tong, Akihiro Yasue and 10 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 4 countries.

Qiqiao DuDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17165, Sweden.
Jieyu WuDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17165, Sweden.ORCID 0000-0002-7063-6990
Carina FischerDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17165, Sweden.
Takahiro SekiDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17165, Sweden.ORCID 0000-0001-8910-4612
Xu JingDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17165, Sweden.
Juan GaoDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17165, Sweden.
Xingkang HeDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17165, Sweden.
Kayoko HosakaDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17165, Sweden.ORCID 0000-0001-9488-8669
Le TongDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm 17164, Sweden.
Akihiro YasueDepartment of Orthodontics Dentofacial Orthopedics, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8504, Japan.ORCID 0000-0002-4889-2285
Masato MiyakeDivision of Molecular Biology, Institute of Advanced Medical Sciences, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
Mitsuaki SobajimaDivision of Molecular Biology, Institute of Advanced Medical Sciences, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.ORCID 0000-0001-6602-7001
Seiichi OyadomariDivision of Molecular Biology, Institute of Advanced Medical Sciences, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.ORCID 0000-0001-6766-1485
Xiaoting SunDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17165, Sweden.
Yunlong YangDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17165, Sweden.ORCID 0000-0003-1551-9828
Qinjun ZhouState Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Shandong Eye Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Qingdao 271000, China.
Minghua GeDepartment of Head and Neck Surgery, Center of Otolaryngology-Head and Neck Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou 31003, China.ORCID 0000-0001-6726-6418
Wei TaoCenter for Nanomedicine and Department of Anaesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-4277-3728
Shuzhong YaoDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China.
Yihai CaoDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17165, Sweden.ORCID 0000-0003-1308-0065
Karolinska Institutet · SETokushima University · JPSun Yat-sen University · CNBrigham and Women's Hospital · USFudan University · CNShandong First Medical University · CNWenzhou Medical University · CNZhejiang Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brown adipose tissue (BAT) is a highly specialized adipose tissue in its immobile location and size during the entire adulthood. In response to cold exposure and other β3-adrenoreceptor stimuli, BAT commits energy consumption by nonshivering thermogenesis (NST). However, the molecular machinery in controlling the BAT mass in adults is unknown. Here, we show our surprising findings that the BAT mass and functions can be manipulated in adult animals by controlling BAT adipocyte differentiation in vivo. Platelet-derived growth factor receptor α (PDGFα) expressed in BAT progenitor cells served a signaling function to avert adipose progenitor differentiation. Genetic and pharmacological loss-of-function of PDGFRα eliminated the differentiation barrier and permitted progenitor cell differentiation to mature and functional BAT adipocytes. Consequently, an enlarged BAT mass (megaBAT) was created by PDGFRα inhibition owing to increases of brown adipocyte numbers. Under cold exposure, a microRNA-485 (miR-485) was identified as a master suppressor of the PDGFRα signaling, and delivery of miR-485 also produced megaBAT in adult animals. Noticeably, megaBAT markedly improved global metabolism, insulin sensitivity, high-fat-diet (HFD)-induced obesity, and diabetes by enhancing NST. Together, our findings demonstrate that the adult BAT mass can be increased by blocking the previously unprecedented inhibitory signaling for BAT progenitor cell differentiation. Thus, blocking the PDGFRα for the generation of megaBAT provides an attractive strategy for treating obesity and type 2 diabetes mellitus (T2DM).

Indexed as

AdipocytesAdipocytes, BrownAdipogenesisAdipose Tissue, BrownMicroRNAsReceptor, Platelet-Derived Growth Factor alphaAnimalsDiabetes Mellitus, Type 2Energy MetabolismObesityThermogenesisMicroRNAsReceptor, Platelet-Derived Growth Factor alphabrown adipose tissuemetabolismnonshivering thermogenesisplatelet-derived growth factor receptor α

Identifiers

PMID36161914
PMCPMC9546542
OpenAlexW4297093907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.